Caring for adults with congenital cardiac disease: successes and challenges for 2007 and beyond

Joseph A Dearani1, Heidi M Connolly, Richard Martinez

  • 1Division of Cardiovascular Surgery, Cardiovascular Diseases Mayo Clinic, Rochester, Minnesota 55905, United States of America. dearani.joseph@mayo.edu

Cardiology in the Young
|December 6, 2007
PubMed

Insights

Adults with congenital heart disease need lifelong care. Improving surveillance and care requires patient education and smooth transitions from pediatric to adult medical services.

Area of Science:

  • Cardiology
  • Adult Congenital Heart Disease (ACHD)
  • Lifelong Medical Care

Background:

  • Patients with congenital cardiac disease require continuous medical attention throughout their lives.
  • Challenges in ACHD care include procedural site selection, antenatal/peripartum management, and multidisciplinary subspecialty support (nephrology, hepatology, etc.).
  • Key issues in the US include neglected ACHD patients, inadequate infrastructure, and difficulties with family planning and pregnancy management.

Purpose of the Study:

  • To outline common problems faced by ACHD patients and the medical community.
  • To identify challenges in establishing comprehensive ACHD care programs.
  • To review the spectrum of diseases and operations in adult congenital cardiac disease patients at a tertiary care center.

Main Methods:

  • Review of common problems and challenges in ACHD care.
  • Analysis of factors contributing to inadequate patient surveillance.
  • Discussion of strategies for improving care, including patient education and transition protocols.

Main Results:

  • Many ACHD patients lack appropriate surveillance due to loss to follow-up, insufficient patient/family education, and lack of adult physician training.
  • Effective ACHD care necessitates multidisciplinary collaboration (imaging, catheterization, surgery, heart failure, transplantation, etc.).
  • Specialized services for pregnancy in women with complex congenital heart disease are limited but essential, requiring close collaboration between obstetricians, cardiologists, and neonatologists.

Conclusions:

  • ACHD patients require lifelong, expert, comprehensive care, as they are rarely cured.
  • Improving ACHD care involves educating patients and families early, facilitating seamless transition to adult care, and developing specialized multidisciplinary clinics.
  • Enhanced collaboration and increased availability of experienced personnel are crucial for improving ACHD care in the coming decade.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.